Scopine Ester Synthesis via Mild Base Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing tiotropium bromide face challenges in controlling scopoline impurities and achieving high purity, particularly due to harsh conditions and low yields when using esterification steps in pharmaceutical production.
Innovation Solution
A new method involving the reaction of scopine with oxalic acid derivatives in the presence of a weak base and a catalyst, followed by reaction with 2-thienylmagnesium bromide, allows for the efficient synthesis of scopine ester with improved purity and yield, avoiding the formation of scopoline impurities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If strongly basic conditions and high temperatures are used for transesterification, then the reaction proceeds efficiently, but the risk of side reactions and impurity formation increases
Solution Approach 1:
The patent changes the reaction parameters by using mild basic conditions (pH 7-10) instead of strongly basic conditions, and conducting the reaction at ambient temperature rather than high temperature. This resolves the contradiction by achieving acceptable reaction efficiency while eliminating scopoline impurity formation through parameter optimization.
Solution Approach 2:
The patent introduces a silyl protecting group as an intermediary to mask the hydroxyl group of scopine during the transesterification reaction. This prevents the hydroxyl group from participating in side reactions that would form scopoline impurities, while still allowing the main reaction to proceed efficiently.
2Productivity
If metallic sodium or strong bases are used as catalysts, then the transesterification reaction proceeds, but the process becomes hazardous and difficult to control at industrial scale
Solution Approach 1:
The patent replaces dangerous, long-lived strong bases like metallic sodium with mild, easily controllable bases such as carbonates or bicarbonates that can be safely handled and disposed of. These milder bases provide sufficient catalytic activity while dramatically improving process safety and controllability at industrial scale.
Solution Approach 2:
The patent changes the pH range from strongly basic (pH >12) to mildly basic (pH 7-10), which maintains adequate reaction rate while eliminating the safety hazards associated with strong bases. This parameter change makes the process reliable and controllable for industrial production.
3Productivity
If the reaction is carried out in a melt at high temperature, then the reaction proceeds, but the risk and complexity of the process increases
Solution Approach 1:
The patent changes the temperature parameter from high temperature (melting point conditions) to ambient or mild heating conditions. This eliminates the need for complex temperature control systems and reduces process complexity while maintaining reaction progression through the use of milder conditions and protecting groups.
4Quantity of substance
If conventional transesterification methods are used, then the scopine ester can be produced, but the purity is limited and requires extensive purification
Solution Approach 1:
The patent performs preliminary protection of the hydroxyl group with a silyl group before the transesterification reaction. This preliminary action prevents impurity formation during the reaction, resulting in high purity product that requires minimal purification. The protecting group is then easily removed in a final step to give the desired high-purity scopine ester.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves scopine ester with a purity of 80-99% and a distinct crystalline form, enhancing the control over impurities and improving the overall yield and purity of tiotropium bromide production.
Implementation Method 1
reaction of scopine with derivatives of oxalic acid in the presence of a weak base and a catalyst, followed by reaction with 2-thienylmagnesium bromide
Implementation Method 2
The reaction is carried out by cooling the reaction mixture to a temperature of -10°C to 15°C, followed by controlled addition of 2-thienylmagnesium bromide
Implementation Method 3
isolating the resulting scopine ester and crystallizing it from a crystallization solvent
Data Source
Figure 1a
Figure 1b
AI summary
The invention relates to a preparation method of the scopine ester of di-(2- thienyl)glycolic acid of formula I. The scopine ester of formula I is an important intermediate in the synthesis of tiotropium bromide, the substance with the chemical name (1R,2R,4S,5S,7S)-7-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)-9,9-dimethyl-3- oxa-9-azatricyclo[3.3.1.02'4]nonan-9-ium bromide of formula II. The method consists of the following steps, reaction of scopine of formula III with derivatives of oxalic acid of formula XIII, wherein X means F, CI, Br, I, and R is X or O-terf-butyl, O-methyl, A/-pyrrolidinyl, N-morpholinyl and /V-imidazolyl, in the presence of a weak base and a catalyst in an inert organic solvent, producing the derivative of formula XIV; reaction of the derivative of formula XIV with at least 2 equivalents of 2- thienylmagnesium bromide of formula XV; and isolating the resulting scopine ester of formula I is then and crystallization from a crystallization solvent.